<p>Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update</p>
نویسندگان
چکیده
منابع مشابه
Bacillus Calmette-Guérin (BCG) Infection Following Intravesical BCG Administration as Adjunctive Therapy For Bladder Cancer
Bacillus Calmette-Gu erin (BCG) is the most effective intravesical immunotherapy for superficial bladder cancer. Although generally well tolerated, BCG-related infectious complications may occur following instillation. Much of the current knowledge about this complication comes from single case reports, with heterogeneous diagnostic and therapeutic approaches and no investigation on risk factor...
متن کاملPricing and Reimbursement Analysis of Bacillus Calmette-Guérin (BCG) Immunotherapy for Bladder Cancer.
RESULTS According to the European Association of Urology (EAU) Guidelines for non-muscle invasive bladder cancer (NMIBC) bladder preservation strategies available include: intravesical immunotherapy, intravesical chemotherapy, device-assisted therapy and combination therapy. In Serbia, there are three medicines listed for chemotherapy (doxorubicin, epirubicin and mitomycin) and one for intraves...
متن کاملVariability of Bcg Strains (bacillus Calmette-guérin)
Three different cultures of BCG propagated for over 2 years in a liquid medium containing Tween 80 and albumin were found to differ in several of their intrinsic properties. Cultures of the three strains were found to consist of morphologically heterogeneous populations-each culture being made up of three main colonial types-spreading, intermediate, and non-spreading. The percentage distributio...
متن کاملUse of bacille Calmette-Guérin in superficial bladder cancer.
Intravesical bacille Calmette-Guérin (BCG) has been used by urologists for several years after its first reported use as a cancer therapy in the 1930s. Morales in 1976 described the usage of BCG as a once weekly intravesical instillation for six weeks; this is a treatment regimen that still exists today. Its success as a treatment depends on it being used appropriately. It is employed: (1) to t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: ImmunoTargets and Therapy
سال: 2020
ISSN: 2253-1556
DOI: 10.2147/itt.s202006